Permanent pacing as treatment for hypertrophic cardiomyopathy
Authors:
- Kenneth M. McDonaldKMKenneth M. McDonald
- Brian MaurerBMBrian Maurer
- 1 July 1991
- journal article
- editorial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (1) , 108-110
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathyEuropean Heart Journal, 1988
- Mitral valve closure and left ventricular filling time in patients with VDD pacemakers. Assessment of the onset of left ventricular systole and the end of diastole.Heart, 1986
- Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A reviewProgress in Cardiovascular Diseases, 1985
- Chronic verapamil therapy in pediatrie and young adult patients with hypertrophic cardiomyopathyThe American Journal of Cardiology, 1984
- Effect of verapamil on retrograde atrioventricular nodal conduction in the human heartJACC, 1983
- Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy.Circulation, 1981
- Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.Circulation, 1978
- Idiopathic hypertrophic subaortic stenosisThe American Journal of Cardiology, 1974
- Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathyHeart, 1970